Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Computer assisted quantitative immunofluorescence of tumor tissue marker expression and clinical outcome to chemotherapy in advanced breast cancer patients.

Tkaczuk KH, Tait NS, Ioffe O, Tan M, Goloubeva OG, Lesko SA, Deamond SF, Zhou D, Lum ZP, Sutula MJ, Van Echo D, Ts'o PO.

Discov Med. 2011 Jul;12(62):33-40.

2.

Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.

Ali A, Furusato B, Ts'o PO, Lum ZP, Elsamanoudi S, Mohamed A, Srivastava S, Moul JW, Brassell SA, Sesterhenn IA, McLeod DG.

Pathol Int. 2010 Oct;60(10):667-72. doi: 10.1111/j.1440-1827.2010.02584.x.

PMID:
20846264
3.

The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method.

Tkaczuk KH, Goloubeva O, Tait NS, Feldman F, Tan M, Lum ZP, Lesko SA, Van Echo DA, Ts'o PO.

Breast Cancer Res Treat. 2008 Sep;111(2):355-64. Epub 2007 Dec 7.

PMID:
18064568
4.

Inhibition of thymidylate synthase activity by antisense oligodeoxynucleotide and possible role in thymineless treatment.

Lin SB, Ts'o PO, Sun SK, Choo KB, Yang FY, Lim YP, Tsai HL, Au LC.

Mol Pharmacol. 2001 Sep;60(3):474-9.

PMID:
11502877
5.

Identification and characterization of circulating prostate carcinoma cells.

Wang ZP, Eisenberger MA, Carducci MA, Partin AW, Scher HI, Ts'o PO.

Cancer. 2000 Jun 15;88(12):2787-95.

PMID:
10870062
6.

Intrabody tissue-specific delivery of antisense conjugates in animals: ligand-linker-antisense oligomer conjugates.

Duff RJ, Deamond SF, Roby C, Zhou Y, Ts'o PO.

Methods Enzymol. 2000;313:297-321. No abstract available.

PMID:
10595363
7.

Influence of sextant prostate needle biopsy or surgery on the detection and harvest of intact circulating prostate cancer cells.

Polascik TJ, Wang ZP, Shue M, Di S, Gurganus RT, Hortopan SC, Ts'o PO, Partin AW.

J Urol. 1999 Sep;162(3 Pt 1):749-52.

PMID:
10458358
8.

Tissue distribution and metabolism of the [32P]-labeled oligodeoxynucleoside methylphosphonate-neoglycopeptide conjugate, [YEE(ah-GalNAc)3]-SMCC-AET-pUmpT7, in the mouse.

Hangeland JJ, Flesher JE, Deamond SF, Lee YC, Ts'O PO, Frost JJ.

Antisense Nucleic Acid Drug Dev. 1997 Jun;7(3):141-9.

PMID:
9212904
9.

Detection of intact prostate cancer cells in the blood of men with prostate cancer.

Ts'o PO, Pannek J, Wang ZP, Lesko SA, Bova GS, Partin AW.

Urology. 1997 Jun;49(6):881-5.

PMID:
9187695
11.

Interstrand complex formation of purine oligonucleotides and their nonionic analogs: the model system of d(AG)8 and its complement, d(CT)8.

Trapane TL, Hogrefe RI, Reynolds MA, Kan LS, Ts'o PO.

Biochemistry. 1996 Apr 30;35(17):5495-508.

PMID:
8611541
13.
14.

Two-dimensional electrophoresis southern transfer method for detecting human genome variability using a LINE-1 sequence probe.

Nakashima H, Yi M, Ichikawa N, LeBlond GF, Antonarakis SE, Ts'o PO.

Anal Biochem. 1995 May 20;227(2):319-27.

PMID:
7573953
15.

Cellular uptake of oligodeoxyribonucleoside methylphosphonates.

Levis JT, Butler WO, Tseng BY, Ts'o PO.

Antisense Res Dev. 1995 Winter;5(4):251-9.

PMID:
8746774
16.

Triple-strand-forming methylphosphonate oligodeoxynucleotides targeted to mRNA efficiently block protein synthesis.

Reynolds MA, Arnold LJ Jr, Almazan MT, Beck TA, Hogrefe RI, Metzler MD, Stoughton SR, Tseng BY, Trapane TL, Ts'o PO, et al.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12433-7.

17.

A sensitive assay for the IFN-regulated 2-5A synthetase enzyme.

Hassel BA, Ts'o PO.

J Virol Methods. 1994 Dec;50(1-3):323-34.

PMID:
7536199
18.

Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1.

Kulka M, Smith CC, Levis J, Fishelevich R, Hunter JC, Cushman CD, Miller PS, Ts'o PO, Aurelian L.

Antimicrob Agents Chemother. 1994 Apr;38(4):675-80.

19.

Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteers.

Hendrix CW, Margolick JB, Petty BG, Markham RB, Nerhood L, Farzadegan H, Ts'o PO, Lietman PS.

Antimicrob Agents Chemother. 1993 Mar;37(3):429-35.

20.

Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5.

Kulka M, Wachsman M, Miura S, Fishelevich R, Miller PS, Ts'o PO, Aurelian L.

Antiviral Res. 1993 Feb;20(2):115-30.

PMID:
8384823
21.

Construction of restriction fragment maps of 50- to 100-kilobase DNA.

Yi M, Ichikawa N, Ts'o PO.

Methods Enzymol. 1993;218:651-71. No abstract available.

PMID:
8389971
22.

Nonionic oligonucleotide analogs (Matagen) as anticodic agents in duplex and triplex formation.

Ts'o PO, Aurelian L, Chang E, Miller PS.

Ann N Y Acad Sci. 1992 Oct 28;660:159-77. No abstract available.

PMID:
1340119
23.

A procedure for the construction of linear restriction fragment maps of a 50- to 100-kb DNA.

Ichikawa N, Yi M, Ts'o PO.

Anal Biochem. 1992 Feb 14;201(1):158-65.

PMID:
1535761
25.

NMR studies of intracellular water at 300 MHz: T2-specific relaxation mechanisms in synchronized or EGF-stimulated cells.

Callahan DE, Deamond SF, Creasey DC, Trapane TL, Bruce SA, Ts'o PO, Kan LS.

Magn Reson Med. 1991 Nov;22(1):68-80.

PMID:
1798396
26.

Antisense inhibition of ras p21 expression that is sensitive to a point mutation.

Chang EH, Miller PS, Cushman C, Devadas K, Pirollo KF, Ts'o PO, Yu ZP.

Biochemistry. 1991 Aug 27;30(34):8283-6.

PMID:
1883816
27.

Expression of the intracisternal A particle endogenous retrovirus genes over the lifetime of mouse and Syrian hamster.

Brown AR, Ts'o PO, Cutler RG.

Arch Gerontol Geriatr. 1991 Jul-Aug;13(1):15-30.

PMID:
15374432
28.

Studies of the T1 and T2 of intracellular water as a function of frequency in normal and transformed fetal cells.

Callahan DE, Trapane TL, Deamond SF, Kao G, Ts'o PO, Kan LS.

Cell Biophys. 1991 Jun;18(3):193-202.

PMID:
1726531
29.

Proton NMR and optical spectroscopic studies on the DNA triplex formed by d-A-(G-A)7-G and d-C-(T-C)7-T.

Kan LS, Callahan DE, Trapane TL, Miller PS, Ts'o PO, Huang DH.

J Biomol Struct Dyn. 1991 Apr;8(5):911-33.

PMID:
1652260
31.

Nonionic oligonucleotide analogues (Matagen) as anticodic agents in duplex and triplex formation.

Ts'o PO.

Antisense Res Dev. 1991 Fall;1(3):273-6. Review. No abstract available.

PMID:
1821647
33.

Two classes of continuous cell lines established from Syrian hamster 9 day gestation embryos: preneoplastic cells and progenitor cells.

Okeda T, Yokogawa Y, Ueo H, Bury MA, Ts'o PO, Bruce SA.

In Vitro Cell Dev Biol. 1990 Dec;26(12):1157-66.

PMID:
2079462
34.

Monitoring mammalian genome rearrangement with mid-repetitive sequences as probes.

Au LC, Ts'o PO, Yi M.

Anal Biochem. 1990 Nov 1;190(2):326-30.

PMID:
2127162
35.

Disposition and metabolism of oligodeoxynucleoside methylphosphonate following a single i.v. injection in mice.

Chen TL, Miller PS, Ts'o PO, Colvin OM.

Drug Metab Dispos. 1990 Sep-Oct;18(5):815-8. No abstract available. Erratum in: Drug Metab Dispos Biol Fate Chem 1991 Nov-Dec;19(6):1165. Chem TL [corrected to Chen TL].

PMID:
1981742
36.
37.

Tumor promoters retard the loss of a transient subpopulation of cells in low passage Syrian hamster cell cultures.

Ueo H, Nakano S, Ts'o PO, Bruce SA.

J Cell Physiol. 1990 Mar;142(3):505-13.

PMID:
2312613
38.
39.

Epitopic discrimination by monoclonal antibodies directed against the same alkylated nucleoside.

Yuhasz SC, Ts'o PO, Kan LS, Adamkiewicz J, Rajewsky M.

J Biomol Struct Dyn. 1989 Aug;7(1):151-65.

PMID:
2479396
40.

A general method for detecting rearrangements in a bacterial genome.

Au LC, Ts'o PO.

Proc Natl Acad Sci U S A. 1989 Jul;86(14):5507-11.

41.

High-frequency 1H NMR studies of the effects of growth factors and phorbol esters on normal Syrian hamster diploid fibroblast cells.

Boal JH, Deamond SF, Callahan DE, Bruce SA, Ts'o PO, Kan LS.

Cell Biophys. 1989 Jun;14(3):245-56.

PMID:
2472211
42.

Simultaneous in situ detection of beta-interferon mRNA and DNA in the same cell.

Tang FJ, Ts'o PO, Lesko SA.

J Histochem Cytochem. 1989 May;37(5):697-701.

PMID:
2703705
43.
44.

Discriminatory 32P 3'-end labeling of restriction endonuclease co-digested DNA fragments.

LeBlond GF, Ts'o PO.

Anal Biochem. 1989 Mar;177(2):413-8.

PMID:
2543232
45.
46.

Modulation of ras expression by anti-sense, nonionic deoxyoligonucleotide analogs.

Brown D, Yu ZP, Miller P, Blake K, Wei C, Kung HF, Black RJ, Ts'o PO, Chang EH.

Oncogene Res. 1989;4(4):243-52.

PMID:
2671865
47.

Sequence specific inhibition of in vitro translation of mutated or normal ras p21.

Yu ZP, Chen DF, Black RJ, Blake K, Ts'o PO, Miller P, Chang EH.

J Exp Pathol. 1989;4(2):97-108.

PMID:
2671311
48.

DNA replication in Syrian hamster cells transiently exposed to hydroxyurea.

Creasey DC, Ts'o PO.

Cancer Res. 1988 Nov 15;48(22):6298-302.

49.

Phosphate catalyzed exchange rates of NH-N protons of DNA.

Fritzsche H, Kan LS, Weller K, Scheiding W, Kast JR, Ts'o PO.

J Biomol Struct Dyn. 1988 Oct;6(2):383-90.

PMID:
2856038
50.

DNA damage induced in mammalian cells by active oxygen species.

Zheng RL, Lesko SA, Ts'o PO.

Sci Sin B. 1988 Jun;31(6):676-86.

PMID:
2851168

Supplemental Content

Support Center